Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 145 participants.
Also called NCT05001074
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 145 participants
- Sponsor
- Registry
-
NCT05001074
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Unknown status
Technical summary
Registry record NCT05001074. Randomized; no masking; primary purpose treatment. Start 2020-07-28 (actual); primary completion 2024-08-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients
- Acronym
- REVOLUTION
- Condition
- Lung Transplant; Complications
- Intervention (Drug)
- Extended release tacrolimus
- Intervention (Drug)
- Immediate release tacrolimus
- Lead sponsor
- Heleen Grootjans
- Collaborator
- Chiesi Farmaceutici S.p.A.
Record details
- Record id
cardio:ct-nct05001074- Content hash
63263b2927cb5b708f8f1a4cc6a6c0026c4c21599c731d21a4641c0c9e013d44